Cargando…

Comparative Effectiveness of β-lactams Vs Azithromycin for Treatment of Outpatient Pediatric Community-acquired Pneumonia

BACKGROUND: Guidelines recommend amoxicillin as first-line therapy for mild, community-acquired pneumonia (CAP) in healthy, immunized children because of its effectiveness against S. pneumoniae. However, macrolides, which have inferior anti-pneumococcal activity, are the most commonly prescribed cla...

Descripción completa

Detalles Bibliográficos
Autores principales:	Handy, Lori, Gerber, Jeffrey S, Bryan, Matthew, Zaoutis, Theoklis, Feemster, Kristen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2017
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5630985/ http://dx.doi.org/10.1093/ofid/ofx162.007

Ejemplares similares

Impact of Personalized Audit and Feedback on Management of Pediatric Outpatient Community-Acquired Pneumonia
por: Handy, Lori, et al.
Publicado: (2017)

175. Randomized Double-blind Controlled Trial of Short vs. Standard Course Outpatient Therapy of Community Acquired Pneumonia in Children (SCOUT-CAP)
por: Williams, Derek, et al.
Publicado: (2020)

Effects of clinical pathway implementation on antibiotic prescriptions for pediatric community-acquired pneumonia
por: Donà, Daniele, et al.
Publicado: (2018)

1297. Azithromycin vs Beta Lactams in Acute Exacerbations of COPD
por: Kale-Pradhan, Pramodini, et al.
Publicado: (2021)

Doxycycline vs. macrolides in combination with a β-lactam antibiotic for the treatment of community-acquired pneumonia in inpatients
por: Aldhahri, Raghad K., et al.
Publicado: (2022)

Additional effect of azithromycin over β-lactam alone for severe community-acquired pneumonia-associated acute respiratory distress syndrome: a retrospective cohort study
por: Suzuki, Jun, et al.
Publicado: (2022)

Appropriate prescribing of azithromycin for community‐acquired pneumonia
por: Qian, Sue, et al.
Publicado: (2022)

Comparative efficacy of azithromycin versus clarithromycin in combination with beta-lactams to treat community-acquired pneumonia in hospitalized patients: a systematic review
por: Al-Salloum, Jumana, et al.
Publicado: (2021)

Treatment of Staphylococcus aureus Bacteremia in Children: Is Intravenous Therapy Always Needed?
por: Dona, Daniele, et al.
Publicado: (2017)

Comparative Treatment Failure Rates of Respiratory Fluoroquinolones or β-Lactam + Macrolide Versus β-Lactam Alone in the Treatment for Community-Acquired Pneumonia in Adult Outpatients: An Analysis of a Nationally Representative Claims Database
por: Lee, Meng-Tse Gabriel, et al.
Publicado: (2015)

Respiratory Fluoroquinolones Monotherapy vs. β-Lactams With or Without Macrolides for Hospitalized Community-Acquired Pneumonia Patients: A Meta-Analysis
por: Liu, Sitong, et al.
Publicado: (2019)

Treatment of extended-spectrum β-lactamase-producing Enterobacteriaceae (ESBLs) infections: what have we learned until now?
por: Pana, Zoi Dorothea, et al.
Publicado: (2018)

2309. Promoting Healthcare Worker (HCW) Use of Personal Protective Equipment in Pediatric Ambulatory Settings
por: Odeniyi, Folasade, et al.
Publicado: (2018)

Comparative Treatment Failure Rates of Respiratory Fluoroquinolones or β-Lactam + Macrolide Versus β-Lactam Alone in the Treatment for Community-Acquired Pneumonia in Adult Outpatients: An Analysis of a Nationally Representative Claims Database: Erratum
Publicado: (2015)

2197. Ceftriaxone Monotherapy vs. Ceftriaxone Plus Azithromycin for the Treatment of Community-Acquired Pneumonia in Hospitalized, Non-ICU Patients
por: Murter, Forrest, et al.
Publicado: (2019)

Adverse Effects from Antibiotics for Acute Respiratory Tract Infections in Children: Comparison of Two Data Sources
por: Gerber, Jeffrey S, et al.
Publicado: (2017)

1329 Impact of an antimicrobial order auto-stop on clinical outcomes at a single institution
por: Ross, Rachael, et al.
Publicado: (2014)

2590. Efficacy of Doxycycline Versus Azithromycin in Community Acquired Pneumonia
por: Mei, Julie, et al.
Publicado: (2023)

Quality of antibiotic prescribing for pediatric community-acquired Pneumonia in outpatient care
por: Saatchi, Ariana, et al.
Publicado: (2023)

Azithromycin combination therapy for community-acquired pneumonia: propensity score analysis
por: Ito, Akihiro, et al.
Publicado: (2019)

370 The Impact of Early Life Antibiotic Exposure on Childhood Weight Gain
por: Gerber, Jeffrey S., et al.
Publicado: (2014)

Is β-Lactam Plus Macrolide More Effective than β-Lactam Plus Fluoroquinolone among Patients with Severe Community-Acquired Pneumonia?: a Systemic Review and Meta-Analysis
por: Lee, Jong Hoo, et al.
Publicado: (2017)

Azithromycin Versus Beta-lactams in Hospitalized Patients with Acute Exacerbations of COPD
por: Baalbaki, Nour, et al.
Publicado: (2022)

2207. Impact of an Intervention Bundle on Azithromycin Use and 5-Day Durations of Therapy for Ambulatory Pediatric Community Acquired Pneumonia
por: Weber, Matthew J, et al.
Publicado: (2023)

216. Step-down Therapy With Oral Fluoroquinolones vs. Oral β-Lactams for Hospitalized Adult Patients with Community-Acquired Pneumonia: A Multi-Hospital Cohort Study
por: Petty, Lindsay, et al.
Publicado: (2018)

463 Incidence of Candidemia In Pediatric Liver Transplant Patients
por: De Luca, Maia, et al.
Publicado: (2014)

66. Impact of a Pharmacist-Driven Azithromycin De-escalation Protocol for Community-Acquired Pneumonia
por: Shakeraneh, Pegah, et al.
Publicado: (2020)

Fluoroquinolones versus β-Lactam/β-Lactamase Inhibitors in Outpatients with Chronic Obstructive Pulmonary Disease and Pneumonia: A Nationwide Population-Based Study
por: Lin, Kuan-Yin, et al.
Publicado: (2015)

HealthCare–Associated Infections in the Nursery
por: Coffin, Susan E., et al.
Publicado: (2011)

517. Impact of Doxycycline in Place of Azithromycin for Community-Acquired Pneumonia on Clostridium difficile Infections
por: John, Jamie, et al.
Publicado: (2018)

Procalcitonin Predicts Response to Beta-Lactam Treatment in Hospitalized Children with Community-Acquired Pneumonia
por: Cohen, Jérémie F., et al.
Publicado: (2012)

2558. Predicting β-Lactam Resistance Using Whole Genome Sequencing (WGS) in Klebsiella pneumoniae: The Challenge of β-Lactam Inhibitors
por: Hujer, Andrea, et al.
Publicado: (2018)

371 Outcomes of Enterobacter bloodstream infection in hospitalized children
por: Larru, Beatriz, et al.
Publicado: (2014)

Susceptibility to β-lactams and quinolones of Enterobacteriaceae isolated from urinary tract infections in outpatients
por: Marchisio, Martín, et al.
Publicado: (2015)

Efficacy and Safety of Nemonoxacin in Outpatients with Community-Acquired Pneumonia
por: Zhao, Bo, et al.
Publicado: (2020)

Recent Advances in Community-Acquired Pneumonia: Inpatient and Outpatient
por: Niederman, Michael S.
Publicado: (2007)

The state and consideration for skin test of β-lactam antibiotics in pediatrics
por: Gao, Chunhui, et al.
Publicado: (2023)

Antibiotic Prescribing for Pediatric Community-Acquired Pneumonia at Children’s Hospitals and General Hospitals Following National Guideline Release
por: Tribble, Alison, et al.
Publicado: (2017)

1483. Comparison of Outcomes in Urinary Tract Infections Caused by SPICE Organisms Treated with Non-Carbapenem-β-lactams vs. Non-β-lactams Agents
por: Sapozhnikov, Julia, et al.
Publicado: (2019)

Novel β-Lactam/β-Lactamase Combination Versus Meropenem for Treating Nosocomial Pneumonia
por: Lin, Wei-Ting, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_blvb5cvjjs7u8k3jvopcn428a3